These findings confirm the cytoprotective function of clusterin in breast carcinoma cells and suggest that there is a role for anticlusterin therapy in the treatment of breast carcinomas that mainly express clusterin protein [11,14]. The gene discussed is CLU; the disease is breast carcinoma.